Literature DB >> 30340922

Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages.

Tian-Yi Zhou1, Yu-Lu Zhou1, Mei-Jia Qian1, Yi-Zheng Fang2, Song Ye3, Wen-Xiu Xin4, Xiao-Chun Yang5, Hong-Hai Wu6.   

Abstract

Tumor-associated macrophages (TAMs) has been regarded as the most prominent component in tumor microenvironment. The correlation between TAM density and poor prognosis in Hepatocellular carcinoma (HCC) patients suggests a supportive role for TAMs in tumor progression. Here we employed a co-culture system to interrogate the molecular link between Yes-Associated Protein (YAP) and TAMs chemotaxis in HCC cells. We found that YAP activation was critical for the recruitment of TAMs towards HCC cells. Furthermore, cytokine array and quantitative RT-PCR analyses showed that IL-6 secreted by YAP-activated HCC cells might induce the TAMs recruitment. Interrupting YAP function by statins, the inhibitors of hydroxymethylglutaryl-CoA reductase, could robustly suppress the chemotaxis of TAMs. Together with our findings that the expression levels ofIL-6inhumanHCC tumors were highly correlated with the prognosis of HCC patients, the current study highlight the possibility of improving HCC treatment by targeting YAP-IL-6 mediated TAMs recruitment.
Copyright © 2018 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; Interleukin-6 (IL-6); Tumor microenvironment; Tumor-associated macrophages (TAMs); Yes-Associated Protein (YAP)

Mesh:

Substances:

Year:  2018        PMID: 30340922     DOI: 10.1016/j.jphs.2018.07.013

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  13 in total

1.  YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.

Authors:  Masum M Mia; Dasan Mary Cibi; Siti Aishah Binte Abdul Ghani; Weihua Song; Nicole Tee; Sujoy Ghosh; Junhao Mao; Eric N Olson; Manvendra K Singh
Journal:  PLoS Biol       Date:  2020-12-02       Impact factor: 8.029

Review 2.  The effects of radiation therapy on the macrophage response in cancer.

Authors:  Callum Beach; David MacLean; Dominika Majorova; James N Arnold; Monica M Olcina
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

3.  Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis.

Authors:  Ce Li; Zhenzi Peng; Yizhou Wang; Gloria Lam; Nicholas Nissen; Jie Tang; Xiaopu Yuan; Michael Lewis; Mark I Greene; Stephen J Pandol; Qiang Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-01-27       Impact factor: 4.052

4.  TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.

Authors:  Yuchuan Jiang; Siliang Chen; Qiang Li; Junjie Liang; Weida Lin; Jinying Li; Zhilong Liu; Mingbo Wen; Mingrong Cao; Jian Hong
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

5.  Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.

Authors:  Jikang Yang; Zhiyuan Xing
Journal:  Exp Biol Med (Maywood)       Date:  2021-05-29

6.  YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11.

Authors:  Jing Wang; Tiefang Song; Suiyang Zhou; Xianchao Kong
Journal:  Mol Med       Date:  2019-07-12       Impact factor: 6.354

Review 7.  RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review.

Authors:  Fatéméh Dubois; Emmanuel Bergot; Gérard Zalcman; Guénaëlle Levallet
Journal:  Cell Death Dis       Date:  2019-12-05       Impact factor: 8.469

Review 8.  Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma.

Authors:  Juliane Lokau; Victor Schoeder; Johannes Haybaeck; Christoph Garbers
Journal:  Cancers (Basel)       Date:  2019-11-01       Impact factor: 6.639

Review 9.  Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.

Authors:  Łukasz Zadka; Damian J Grybowski; Piotr Dzięgiel
Journal:  Cell Oncol (Dordr)       Date:  2020-06-02       Impact factor: 6.730

10.  RASSF1A inhibits PDGFB-driven malignant phenotypes of nasopharyngeal carcinoma cells in a YAP1-dependent manner.

Authors:  Ying-Ying Liang; Xu-Bin Deng; Xian-Tao Lin; Li-Li Jiang; Xiao-Ting Huang; Zhi-Wen Mo; Ya-Wei Yuan; Muy-Teck Teh
Journal:  Cell Death Dis       Date:  2020-10-14       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.